{
  "docId": "019de072-f0cb-7745-907c-f9e6b87d2817",
  "docSlug": "e5afd111c5ca3d26ccce5d5b91b81d60",
  "documentTitle": "BioNTech | Investor Day Presentation Deck | 156 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 48,
  "pageCount": 120,
  "prevPage": 47,
  "nextPage": 49,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Hub-and-spoke diagram layout showing central infrastructure and four peripheral capability areas.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de072-f0cb-7745-907c-f9e6b87d2817/48",
  "deckHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817",
  "deckJsonHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817.json",
  "deckAnchorHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817#slide-48",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.16,
        "x": 0.42,
        "y": 0.43
      },
      "kind": "diagram",
      "text": "BioNTech Manufacturing Infrastructure",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7311de0f-8471-4404-b4ce-8e1f085296a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "list",
      "text": "Modular mRNA / BioNTainer: >50M doses/year, sustainable production.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b07fb36-ec9e-4746-a52a-6c82962d8ff7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.55,
        "y": 0.6
      },
      "kind": "list",
      "text": "Cell therapy: ~80,000 sq ft, expertise in vectors and CAR-T/TCR.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6692444d-8956-4022-9063-314b2f29c738",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.45,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Bulk mRNA: End-to-end production, >100k sq ft, >1B doses, flexible.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "88629c7c-fd4e-4ac9-9bd5-878755bf10da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.55,
        "y": 0.2
      },
      "kind": "list",
      "text": "Individualized mRNA: Semi-automated, >1,000 cGMP batches.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0f68bf3-4be3-470c-bf7f-808d6a55e221",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Diversified manufacturing expertise across four distinct capabilities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e35f8fb7-1b74-4f12-9cf1-9f27030addc8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "fdbc79a8-e84e-43ed-ac46-6074e7dd063c",
      "evidence": "list/bullet: Bulk mRNA: End-to-end production, >100k sq ft, >1B doses, flexible. Modular mRNA / BioNTainer: >50M doses/year, sustainable production. Cell therapy: ~80,000 sq ft, expertise in vectors and CAR-T/TCR. Individualized mRNA: Semi-automated, >1,000 cGMP batches.",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "hub-spoke",
      "slug": null,
      "matchId": "5803addc-aa0f-44bd-85e4-612f679153e7",
      "evidence": "Central circle connecting four distinct manufacturing capability quadrants.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}